Principal Investigator

Rani George, M.D., Ph.D.
Associate Professor of Pediatrics
Harvard Medical School
Dana 640
rani_george@dfci.harvard.edu

---

---

Present Members

Bandana Sharma, Ph.D.
Lab Manager
Dana 640A
bandana_sharma@dfci.harvard.edu

---

Hao Huang, Ph.D.  
Louisiana State University
Postdoctoral Fellow
Recipient, Grant Team Path to the Cure
hao_huang@dfci.harvard.edu

---

"My research project focuses on the molecular biology and biochemistry research of ALK, a Receptor Tyrosine Kinase closely related to neuroblastoma."

Satyaki Sengupta, Ph.D.  
Michigan State University
Postdoctoral Fellow
Fellow, Rally Foundation for Childhood Cancer Research and Infinite Love for Kids Fighting Cancer (2019-2021)
satyaki_sengupta@dfci.harvard.edu

---

"My interests are vested in understanding chromatin features underlying aberrant gene expression in neuroblastoma (NB). The broad goal is to uncover the role of chromatin in driving the hallmark features of NB such as aberrant proliferation, impaired differentiation and immune evasion."

 Matthew Harlow, Ph.D.  
 Vanderbilt University
 Postdoctoral Fellow
​Recipient, What Would Willie Want Foundation Fellowship
matthew_harlow@dfci.harvard.edu

---

"I am interested in understanding the transcriptional processes that lead to tumor formation. In particular, I want to identify transcriptional dependencies that can be leveraged into improving patient outcomes."

Sanjukta Das, Ph.D.
Indian Institute of Science, Bangalore
Postdoctoral Fellow
sanjukta_das@dfci.harvard.edu

---

"I use integrative computational and statistical methods to analyze genomics and transcriptomics data in order to understand the underlying mechanism of transcription and molecular pathways in tumors."

Marina Volegova, Ph.D.
University of California - Berkeley
Postdoctoral Fellow
marina_volegova@dfci.harvard.edu

---

"My research focus is to investigate how cellular mRNA translation machinery and amplified MYCN in high risk neuroblastoma synergize at the level of translation regulation to drive unique gene expression programs to evade apoptosis and potentiate oncogenic activity."

Cibele Cardoso, Ph.D.
University of Sao Paulo
Postdoctoral Fellow
cibele_cardoso@dfci.harvard.edu

---

Rodolfo Serafim, Ph.D.
University of Sao Paulo
Postdoctoral Fellow
RodolfoB_Serafim@dfci.harvard.edu

---

"My research interest is to investigate the molecular basis of BORIS as an epigenetic modulator of therapeutic resistance and cancer aggressiveness." 




"I am focused on understanding the molecular mechanisms of genomic instability and epigenetic alterations in osteosarcoma.”

Alissa Joy
Administrative Assistant
Dana 640
(617) 582-8633
AlissaL_Joy@dfci.harvard.edu

---